360 High-Risk Vulnerability Immunization Tool V2.0 vs GrammaTech FVA – FPGA Vulnerability Analysis Tools: 2026 Comparison

360 High-Risk Vulnerability Immunization Tool V2.0

Startups and SMBs with Windows-heavy infrastructure and patching backlogs should run 360 High-Risk Vulnerability Immunization Tool V2.0 first; it immunizes against the specific CVEs that drive ransomware campaigns (MS17-010, CVE-2019-0708) without requiring immediate OS updates. The tool supports Windows 7 through current versions and deploys on-premises, meaning air-gapped networks can actually use it. Skip this if you're looking for NIST PR.PS coverage beyond platform hardening,this tool stops known exploits, not supply chain attacks or firmware-level threats.

GrammaTech FVA – FPGA Vulnerability Analysis Tools

Enterprise hardware security teams responsible for custom or third-party FPGA designs need GrammaTech FVA – FPGA Vulnerability Analysis Tools because it's the only tool that automatically reverse engineers bitstreams into human-readable netlists and then hunts for hardware Trojans and design flaws in a single workflow. The platform addresses ID.AM and ID.RA gaps that most vulnerability assessments skip entirely: you get structural asset visibility of your FPGA IP and quantified risk metrics tied to specific vulnerabilities, not just a list of CVEs. Skip this if your FPGAs are off-the-shelf components with published designs; GrammaTech's value proposition is opaque or proprietary designs where you have no other way to audit what's actually running in silicon.